Author: Abhay Panchal

In a move signaling the next leap in GI innovation, Dallas-based Surgical Automations has raised $3.4 million in an oversubscribed seed round co-led by Dr. Fred Moll (founder of Intuitive Surgical) and TurboStart. Operating largely in stealth, the company is developing the Vāsuki Robotic System — a platform combining robotics, sensors, and AI-driven navigation to automate key steps in upper and lower GI procedures. With ambitions to make colonoscopy faster, safer, and more precise, Surgical Automations is now advancing toward pre-clinical validation and its first human trials.

Read More

EndoQuest Robotics is integrating NVIDIA’s IGX Thor platform — built on the Blackwell architecture — to accelerate its next-generation endoluminal surgical robot. The collaboration will combine NVIDIA’s AI stack (Holoscan, CUDA, AI Enterprise) with EndoQuest’s visualization and robotic control systems to enable real-time image processing, precise motion control, and secure cloud intelligence. This move strengthens EndoQuest’s roadmap toward commercializing its flexible robotic system as it advances the PARADIGM Trial in GI and colorectal surgery. [Read more →]

Read More

A new study presented at ACG 2025 showed that patients receiving both in-person and virtual multidisciplinary GI care experienced major improvements in symptom severity, control, and satisfaction — while cutting all-cause costs by up to 25%. The hybrid model, led by dietitians, psychologists, and GI specialists, reduced ER visits and surgeries across nearly 2,000 patients. As Oshi Health’s Dr. Sameer Berry noted, it’s not telehealth vs. traditional care — it’s the combination that’s transforming outcomes.

Read More

United Digestive has partnered with Gastro MD and Gastroenterology of Greater Orlando, adding 32 providers across six clinics and two ASCs in Tampa, Orlando, and Daytona. The collaboration strengthens United Digestive’s position as a leading GI platform in the Southeast—enabling physician-led, integrated care while easing administrative load through advanced infrastructure and innovation support. Both practices will retain their brands as they join forces to expand high-quality digestive health access across Florida. [Read more →]

Read More

This year’s HLTH conference delivered big news: Mark Cuban’s Cost Plus Drugs is joining forces with TrumpRx to shake up drug pricing, Optum unveiled an AI-powered claims platform, and Cedar launched tools to help patients afford care. Oscar Health debuted a menopause-focused ACA plan, while the AMA opened a new digital health and AI center. Knownwell secured $25M from CVS Health Ventures, and Highmark Health partnered with Noom to bring behavior-driven weight management to millions. Each move signals how fast the healthcare landscape is shifting. 

Read More

In part two of his series, Dr. Klaus Mergener shifts from legal basics to the day-to-day realities that shape a GI fellow’s career. From clearly defined clinical and on-call duties to how compensation and benefits are structured, he warns against vague contract language that can quietly expand responsibilities without fair pay. With practical advice on reporting relationships, performance evaluations, and supervisory roles, the piece underscores why clarity upfront can mean the difference between a thriving career and early burnout. [Read more →]

Read More

Results from GRAIL’s registrational PATHFINDER 2 study, presented at ESMO 2025, show that adding the Galleri multi-cancer early detection (MCED) blood test to standard screenings increased cancer detection rates more than seven-fold. Over half of Galleri-detected cancers were found at early stages, when treatment is most effective, and nearly three-quarters of cases were in cancers without current screening options. The test demonstrated high accuracy in identifying cancer signal origin, enabling faster and more efficient diagnostic workups, with a false positive rate of only 0.4%. With FDA submission underway, Galleri positions itself as a potential game-changer in how we approach population-level…

Read More

A new study in Current Medical Research and Opinion found that eliminating patient cost sharing for follow-up colonoscopy after a positive stool-based test led to a 41.2% increase in utilization, with the effect sustained nationwide. The change followed federal actions in January 2023 — tri-department guidance for ACA-compliant/private insurance and a CMS rule extending coverage to Medicare. Researchers analyzed data from 10.8 million colonoscopies (Jan 2022–Nov 2023) using an interrupted time series design, adjusting for seasonal trends. The study notes limitations, including reliance on claims data, short timeframe, and inability to isolate all contributing factors. Still, findings highlight how removing…

Read More

St. Charles Health System partnered with WovenX Health to tackle GI access shortages in Central Oregon. Using WovenX’s OnDemand GI platform, the system avoided hiring new staff yet delivered major gains within six months: Differentiator: WovenX combines AI-enabled intake, intelligent routing, APP-led visits, and real-time physician oversight — creating a scalable, ROI-driven specialty access layer without adding FTEs or new clinics.

Read More